Filing Details
- Accession Number:
- 0001567619-18-001424
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-17 20:46:47
- Reporting Period:
- 2018-08-15
- Accepted Time:
- 2018-08-17 20:46:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1433714 | Castlight Health Inc. | CSLT | Services-Computer Processing & Data Preparation (7374) | 261989091 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1742487 | Maeve O'meara | C/O Castlight Health, Inc. 150 Spear St., Suite 400 San Francisco CA 94105 | Evp,Product&Customerexperience | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common Stock | Acquisiton | 2018-08-15 | 9,000 | $0.00 | 39,881 | No | 4 | M | Direct | |
| Class B Common Stock | Disposition | 2018-08-16 | 3,284 | $2.87 | 36,597 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class B Common Stock | Restricted Stock Units | Disposition | 2018-08-15 | 9,000 | $0.00 | 9,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,000 | No | 4 | M | Direct |
Footnotes
- Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on May 15, 2015, the grant of which was previously reported by the ReportingPerson on a Form 3.
- Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $2.85 to $2.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
- 25% of the RSUs vested on February 15, 2016 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting.
Billionaire Hedge Funds
